Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2019Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injuryGhimire, K.; Chiba, T.; Minhas, N.; Meijles, D.N.; Lu, B.; O'Connell, P.; Rogers, N.M.
2019Toll-like receptor-4 antagonist (+)-naloxone confers sexually dimorphic protection from inflammation-induced fetal programming in miceChin, P.Y.; Dorian, C.; Sharkey, D.J.; Hutchinson, M.R.; Rice, K.C.; Moldenhauer, L.M.; Robertson, S.A.
2019Calmodulin-dependent signalling pathways are activated and mediate the acute inflammatory response of injured skeletal muscleHu, J.; Shi, D.; Ding, M.; Huang, T.; Gu, R.; Xiao, J.; Xian, C.J.; Dong, J.; Wang, L.; Liao, H.
2016Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome compositionWong, M.; Inserra, A.; Lewis, M.; Mastronardi, C.; Leong, L.; Choo, J.; Kentish, S.; Xie, P.; Morrison, M.; Wesselingh, S.; Rogers, G.; Licinio, J.
2015Toll-like receptor 4 Is an essential upstream regulator of on-time parturition and perinatal viability in miceWahid, H.; Dorian, C.; Chin, P.; Hutchinson, M.; Rice, K.; Olson, D.; Moldenhauer, L.; Robertson, S.
2012Renal dendritic cells adopt a pro-inflammatory phenotype in obstructive uropathy to activate T cells but do not directly contribute to fibrosisSnelgrove, S.; Kausman, J.; Lo, C.; Lo, C.; Ooi, J.; Coates, P.; Hickey, M.; Holdsworth, S.; Kurts, C.; Engel, D.; Kitching, R.
2016The Nedd4-2/Ndfip1 axis is a negative regulator of IgE-mediated mast cell activationYip, K.; Kolesnikoff, N.; Hauschild, N.; Biggs, L.; Lopez, A.; Galli, S.; Kumar, S.; Grimbaldeston, M.
2012Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in miceJuarez, J.; Harun, N.; Thien, M.; Welschinger, R.; Baraz, R.; Dela Pena, A.; Pitson, S.; Rettig, M.; DiPersio, J.; Bradstock, K.; Bendall, L.
2017Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomesStevens, N.; Chapman, M.; Fraser, C.; Kuchel, T.; Hayball, J.; Diener, K.